Abstract
In conclusion, this report shows the feasibility of TAVI for the treatment of structural deterioration of a stentless aortic bioprosthesis, suggesting that TAVI might be further considered for the treatment of this highly challenging subset of patients. However, the efficacy and safety of this strategy should be determined in prospective studies with a large number of patients and long-term follow-up.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have